Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature-Reference-Cited by-同舟云学术

Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature

Published:2014-04 Issue:6 Volume:50 Page:1045-1054
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Drukker C.A.,van den Hout H.C.,Sonke G.S.,Brain E.,Bonnefoi H.,Cardoso F.,Goldhirsch A.,Harbeck N.,Honkoop A.H.,Koornstra R.H.T.,van Laarhoven H.W.M.,Portielje J.E.A.,Schneeweiss A.,Smorenburg C.H.,Stouthard J.,Linn S.C.,Schmidt M.K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice;Bueno-de-Mesquita;Ann Oncol,2011

2. A gene-expression signature as a predictor of survival in breast cancer;van de Vijver;N Engl J Med,2002

3. Integraal Kankercentrum Nederland: NABON richtlijn mammacarcinoom; 2012.

4. Microarray technology and its effect on breast cancer (re)classification and prediction of outcome;Cardoso;Breast Cancer Res,2003

5. Clinical application of the 70-gene profile: the MINDACT trial;Cardoso;J Clin Oncol,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort;The Breast;2023-10

2. Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach;Human Pathology Reports;2021-11

3. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis;Health Technology Assessment;2019-06

4. Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe;Cancer Treatment Reviews;2018-01

5. GENE EXPRESSION PROFILING AND EXPANDED IMMUNOHISTOCHEMISTRY TESTS TO GUIDE SELECTION OF CHEMOTHERAPY REGIMENS IN BREAST CANCER MANAGEMENT: A SYSTEMATIC REVIEW;International Journal of Technology Assessment in Health Care;2017